IGES Pharma at the BIO International Convention in Boston - June 5th, 2023

Roundtable discussion: EU Pharmaceutical Environment Crash-Course
A deep-dive discussion into the new procedure for EU Health Technology Assessment

- Opportunities for Joint Scientific Consultations
- How are Joint Clinical Assessments likely to work in practice
- What are the possible methodological approaches
- What are the key issues remaining to be addressed e.g. around lack of opportunities for dialogue, procedure for choice of comparator

Participants:

John A. Murphy, III., Chief Policy Officer Deputy Counsel, Healthcare, Biotechnology Innovation Organization (BIO)
Alexander Natz, EUCOPE
Fabian Berkemeier, Managing Director, IGES Institut
Claire Skentelbury, Secretary General, EuropaBio
Victor Maertens, Government Affairs Director, EUCOPE
Matias Olsen, Public Affairs & Policy Manager, EUCOPE

More information on EU-HTA at the BIO convention can be found here.